PBR Nachrichten

 

This move strengthens vaccine supply resilience in Colombia and creates a pathway for SK bioscience's expansion into Latin America. The Colombian Ministry of Health and Social Protection, National The post SK bioscience and VECOL partner on Colombia vaccine manufacturing initiative appeared first on Pharmaceutical Business review....

Elunetirom is an oral, once daily, brain-penetrant CNS thyroid hormone receptor (CNS-TR) agonist in development for bipolar depression and major depressive disorder (MDD). The therapy is intended as The post Autobahn's elunetirom receives FDA fast track designation to treat adjunctive bipolar appeared first on Pharmaceutical Business review....

The therapy uses patients' immune cells, developed into mature macrophages, which are then re-infused to break down scar tissue and promote the growth of healthy liver cells. In The post University of Edinburgh develops cell therapy for liver disease appeared first on Pharmaceutical Business review....

The recommendation covers the use of the therapy in combination with cetuximab and Folfox as a first-line treatment option for adult patients with BRAFV600E-mutant mCRC. This represents a The post Pierre Fabre's Braftovi gains CHMP positive opinion for mCRC appeared first on Pharmaceutical Business review....

The approval allows Datroway to be used as a first-line treatment for adults with unresectable or metastatic TNBC who cannot receive programmed cell death protein 1 (PD-1) or The post AstraZeneca, Daiichi Sankyo's Datroway receives FDA approval for TNBC appeared first on Pharmaceutical Business review....

The collaboration aims to accelerate hit identification for these companies through a fee-for-success approach. It will combine OpenBench's AI-based discovery platform with Concept Life Sciences' expertise in medicinal The post Concept Life Sciences and OpenBench partner on drug discovery services appeared first on Pharmaceutical Business review....

First announced last month, the move aims to advance Gilead's oncology portfolio. Under the agreement, the company acquired all outstanding equity of Tubulis for $3.15bn upfront on a The post Gilead Sciences acquires Tubulis for $5bn appeared first on Pharmaceutical Business review....

The site is anticipated to expand the company's production capacity for iPSC-based research products and services to four times its previous levels. Fujifilm Cellular Dynamics plans to use The post FUJIFILM opens new iPSC facility in Madison, US appeared first on Pharmaceutical Business review....

The initiative will embed agentic capabilities throughout BMS' research, clinical, manufacturing, commercial, and corporate operations. It aims to shift from basic conversational AI towards advanced agentic tools within The post BMS and Anthropic collaborate for Claude implementation appeared first on Pharmaceutical Business review....

The move aims to allow pharmaceutical and biotechnology researchers to use AI more effectively by leveraging enhanced bioinformatics tools and curated knowledge bases. The integration also aims to The post QIAGEN and NVIDIA partner on AI drug discovery appeared first on Pharmaceutical Business review....

The deal covers the European Union, Iceland, Liechtenstein, Norway, Switzerland, the UK, and the Middle East and North Africa (MENA) region. Idefirix is used to desensitise adult patients The post SERB signs agreement to acquire Idefirix rights for $133.6m appeared first on Pharmaceutical Business review....

The designation follows two randomised, controlled Phase III trials that showed significant pain reduction, good tolerability, and no evidence of dependence. A Phase III comparator study found VER-01 The post VERTANICAL's VER-01 gains FDA breakthrough status for low back pain appeared first on Pharmaceutical Business review....

Helicons are stabilised, cell-penetrant alpha-helical peptides engineered to interact with intracellular protein targets, including those with flat surfaces unsuitable for traditional small molecule engagement. The partnership will investigate The post Regeneron signs $2.32bn deal with Parabilis for Helicon conjugates appeared first on Pharmaceutical Business review....

Jascayd is said to be the first phosphodiesterase 4B (PDE4B) inhibitor with antifibrotic and immunomodulatory effects to be approved for these uses. Japan is the fourth country to The post Japan's MHLW approves Boehringer's Jascayd for IPF and PPF appeared first on Pharmaceutical Business review....

Data from the DESTINY-Breast11 and DESTINY-Breast05 Phase III trials support these approvals. They cover the use of Enhertu in both the neoadjuvant and adjuvant treatment settings for adult The post FDA approves Enhertu for two HER2-positive early breast cancer indications appeared first on Pharmaceutical Business review....

The companies are also launching their first collaboratively developed product, Aridol, and plan to introduce further branded products in the future. The collaboration integrates Arna Pharma's development expertise The post Arna Pharma and Slate Run complete JV for new US company appeared first on Pharmaceutical Business review....

Affecting adults and children, this rare, progressive, genetic disorder impacts both bone and muscle health due to the body's inability to retain sufficient phosphorus, a mineral essential for The post Kyowa Kirin secures FDA approval for Crysvita dosing update appeared first on Pharmaceutical Business review....

The offer was approved by Assertio's Board of Directors, following a revised merger agreement process and is considered a “superior proposal” compared to the previous agreement with Garda The post Zydus to acquire Assertio in $166m deal appeared first on Pharmaceutical Business review....

The approval covers adults and adolescents in the European Union (EU) who weigh at least 35kg and have haemophilia A (factor VIII deficiency) with factor VIII inhibitors, or The post Pfizer receives EC approval for Hympavzi to treat haemophilia appeared first on Pharmaceutical Business review....

With this authorisation, the UAE is said to become the first nation worldwide to approve this treatment, which is offered in 1mg and 2mg doses. This move underscores The post UAE approves AstraZeneca's Baxfendy for hypertension appeared first on Pharmaceutical Business review....